FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Dextrose 5% Injection
Status: Currently in Shortage
»Date first posted: 02/14/2022
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Other; Pediatric

Expand all

B. Braun Medical Inc. (New 02/16/2022)

Company Contact Information:
800-227-2862

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5% 500 mL Excel Bag L5101 (NDC 0264-7510-10) Product on allocation for contracted customers Other
5% 1000 mL Excel Bag L5100 (NDC 0264-7510-00) Product on allocation for contracted customers Other
5% 250 mL Excel Bag L5102 (NDC 0264-7510-20) Product on allocation for contracted customers Other
5% 100 mL PAB Bag S5104-5264 (NDC 0264-1510-32) Product available
5% 50 mL PAB Bag S5104-5364 (NDC 0264-1510-31) Product available
10% 1000 mL Excel Bag L5200 (NDC 0264-7520-00) Product available
10% 500 mL Excel Bag L5201 (NDC 0264-7520-10) Product available
10% 250 mL Excel Bag L5202 (NDC 0264-7520-20) Product on allocation for contracted customers Other

Baxter Healthcare (Revised 04/27/2022)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5% Dextrose Injection, USP, 25 mL VIAFLEX Plastic Container Quad Pack, Product Code 2B0080, (NDC 0338-0017-10) Available on allocation
5% Dextrose Injection, USP, 50 mL VIAFLEX Plastic Container, Product Code 2B0086, (NDC 0338-0017-41) Available on allocation
5% Dextrose Injection, USP, 50 mL VIAFLEX Plastic Container, Quad Pack, Product Code 2B0081, (NDC 0338-0017-11) Available on allocation
5% Dextrose Injection, USP, 50 mL VIAFLEX Plastic Container, Multi Pack, Product Code 2B0088, (NDC 0338-0017-31) Available on allocation
5% Dextrose Injection, USP, 100 mL VIAFLEX Plastic Container, Product Code 2B0087, (NDC 0338-0017-48) Available on allocation
5% Dextrose Injection, USP, 100 mL VIAFLEX Plastic Container, Quad Pack, Product Code 2B0082, (NDC 0338-0017-18) Available on allocation. Recovery late April 2022
5% Dextrose Injection, USP, 100 mL VIAFLEX Plastic Container, Multi Pack, Product Code 2B0089, (NDC 0338-0017-38) Available on allocation
5% Dextrose Injection, USP, 50 mL MINI-BAG Plus Container. Quad Pack, Product Code 2B0040, (NDC 0338-0551-11) Available on allocation
5% Dextrose Injection, USP, 50 mL MINI-BAG Plus Container, Product Code EZPB0040, (NDC 0338-9143-30) Limited supply on allocation, recovery 2023 Demand increase
5% Dextrose Injection, USP, 100 mL MINI-BAG Plus Container, Product Code EZPB0041, (NDC 0338-9147-30) Available on allocation
5% Dextrose Injection, USP, 100 mL MINI-BAG Plus Container, Product Code 2B0041, (NDC 0338-0551-18) Limited supply on allocation, recovery late May 2022 Demand increase
5% Dextrose Injection, USP, 1000 mL VIAFLO Plastic Container, Product Code UE0064D, (NDC 0338-0070-10) Available on allocation
5% Dextrose Injection, USP, 250 mL VIAFLEX Plastic Container, Product Code 2B0062Q, (NDC 0338-0017-02) Available on allocation
5% Dextrose Injection, USP, 250 mL VIAFLO Plastic Container, Product Code UE0062D, (NDC 0338-0062-30) Available on allocation
5% Dextrose Injection, USP, 500 mL VIAFLEX Plastic Container, Product Code 2B0063Q, (NDC 0338-0017-03) Available on allocation
5% Dextrose Injection, USP, 500 mL VIAFLO Plastic Container, Product Code UE0063D, (NDC 0338-0066-20) Available on allocation

Fresenius Kabi USA, LLC (Revised 05/04/2022)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (5 grams per 100 mL) (NDC 63323-624-61) Backordered. Next release May 2022. Increase in Demand
5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (12.5 grams per 250 mL) (NDC 63323-624-74) Backordered. Next release July 2022. Increase in Demand
5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (25 grams per 500 mL) (NDC 63323-624-75) Backordered. Next release May 2022. Increase in Demand
5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (50 grams per 1,000 mL) (NDC 63323-624-10) Backordered. Next release August 2022. Increase in Demand
5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (2.5 grams per 50 mL) (NDC 63323-624-50) Backordered. Next release June 2022. Increase in Demand

Hospira, Inc., a Pfizer Company (Revised 04/29/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mL; ADD-Vantage Flexible Container (Case of 50)(NDC 0409-7100-66) Next Delivery: May 2022; Estimated Recovery: June 2022

Dear Customer Letter: Availability Update for ADD-Vantage™ Flexible Containers (Multiple Presentations)

Demand increase for the drug
100 mL; ADD-Vantage Flexible Container (Case of 50)(NDC 0409-7100-67) Limited Supply Available. Next Delivery: May 2022; Estimated Recovery: September 2022 Check wholesaler for availability; Shortage per Manufacturer: Manufacturing delay

Dear Customer Letter: Availability Update for ADD-Vantage™ Flexible Containers (Multiple Presentations)

Other
250 mL; ADD-Vantage Flexible Container (Case of 24)(NDC 0409-7100-02) Limited Supply Available. Next Delivery: May 2022; Estimated Recovery: September 2022 Check wholesaler for availability; Shortage per Manufacturer: Manufacturing delay

Dear Customer Letter: Availability Update for ADD-Vantage™ Flexible Containers (Multiple Presentations)

Other

ICU Medical, Inc. (Revised 05/05/2022)

Company Contact Information:
877-946-7747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5% Dextrose Injection, USP, 250 mL (Legacy Hospira NDC 0409-7922-02) (ICU Medical NDC 0990-7922-02) Available ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Demand increase for the drug
5% Dextrose Injection, USP, 150 mL (Legacy Hospira NDC 0409-7922-61) (ICU Medical NDC 0990-7922-61) Available ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Demand increase for the drug
5% Dextrose Injection, USP, 50 mL (Legacy Hospira NDC 0409-7923-13) (ICU Medical NDC 0990-7923-13) Allocation ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Demand increase for the drug
5% Dextrose Injection, USP, 25 mL 4-1 (Legacy Hospira NDC 0409-7923-20) (ICU Medical NDC 0990-7923-20) Available ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Demand increase for the drug
5% Dextrose Injection, USP, 100 mL (Legacy Hospira NDC 0409-7923-23) (ICU Medical NDC 0990-7923-23) Unavailable ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Demand increase for the drug
5% Dextrose Injection, USP, 50 mL 4-1 (Legacy Hospira NDC 0409-7923-36) (ICU Medical NDC 0990-7923-36) Unavailable ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Demand increase for the drug
5% Dextrose Injection, USP, 100 mL 4-1 (Legacy Hospira NDC 0409-7923-37) (ICU Medical NDC 0990-7923-37) Allocation ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Demand increase for the drug
5% Dextrose Injection, USP, 500 mL (Legacy Hospira NDC 0409-7922-03) (ICU Medical NDC 0990-7922-03) Available ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.
5% Dextrose Injection, USP, 500 mL (Legacy Hospira NDC 0409-7922-55) (ICU Medical NDC 0990-7922-55) Available ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.
5% Dextrose Injection, USP, 50 mL VisIV™ Container (Legacy Hospira NDC 0409-7923-06) (ICU Medical NDC 0990-7923-06) Available ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.
5% Dextrose Injection, USP, 100 mL VisIV™ Container (Legacy Hospira NDC 0409-7923-11) (ICU Medical NDC 0990-7923-11) Available ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.
5% Dextrose Injection, USP, 250 mL VisIV™ Container (Legacy Hospira NDC 0409-7922-25) (ICU Medical NDC 0990-7922-25) Available ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.
5% Dextrose Injection, USP, 1000 mL (Legacy Hospira NDC 0409-7922-09) (ICU Medical NDC 0990-7922-09) Available ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English